FOI_8416

Internal Reference Number: FOI_8416

Date Request Received: 30/01/2025 00:00:00

Date Request Replied To: 15/02/2025 00:00:00

This response was sent via: By Email

Request Summary: Dermatology medication

Request Category: Private Individuals


Question Number 1: I have a FOI request, that I hope you would be able to assist me with. For patients treated by the dermatology department with Dupilumab in the latest four months (September to December 2024), could you please tell us: a. how many patients were treated in the previous 4-month period (May to August 2024) with Dupilumab? b. how many patients were treated in the previous 4-month period (May to August 2024) with any of the following advanced therapies: abrocitinib, baricitinib, tralokinumab, upadacitinib and lebrikizumab? c. how many patients were treated in the previous 4-month period (May to August 2024) with any of the following immunosuppressants: Methotrexate, Ciclosporin, Mycophenolate or Azathioprine? d. how many patients were treated in the previous 4-month period (May to August 2024) with any other treatment? (e.g. Acitretin, Alitretoin, Pimecrolimus, Tacrolimus, oral corticosteroids , topical steroids)

Answer To Question 1: a) Dupilumab = 23 b) Abrocitinib = <5, others = 0 c) Methotrexate, Ciclosporin, Mycophenolate or Azathioprine = 0 d) Pimecrolimus = <5, others = 0

Question Number 2: For patients treated by the dermatology department with Dupilumab in the four months from May to August 2024, could you please let us: a. how many patients were treated in the subsequent 4-month period (September to December 2024) with Dupilumab? b. how many patients were treated in the subsequent 4-month period (September to December 2024) with any of the following advanced therapies: abrocitinib, baricitinib, tralokinumab, upadacitinib and lebrikizumab? c. how many patients were treated in the subsequent 4-month period (September to December 2024) with any of the following immunosuppressants: Methotrexate, Ciclosporin, Mycophenolate or Azathioprine? d. how many patients were treated in the subsequent 4-month period (September to December 2024) with any other treatment? (e.g. Acitretin, Alitretoin, Pimecrolimus, Tacrolimus, oral corticosteroids , topical steroids)

Answer To Question 2: a) Dupilumab = 27 b) upadacitinib = <5, others = 0 c) Methotrexate, Ciclosporin, Mycophenolate or Azathioprine = 0 d) Acitretin = <5, Tacrolimus = <5, topical steroids = 6, others = 0

To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.